CC
Casdin Capital Portfolio holdings
AUM
$1.1B
This Quarter Return
-1.14%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$3.36B
AUM Growth
+$3.36B
(-0.1%)
Cap. Flow
+$170M
Cap. Flow
% of AUM
5.07%
Top 10 Holdings %
Top 10 Hldgs %
63.12%
Holding
55
New
4
Increased
15
Reduced
6
Closed
6
Top Buys
| 1 |
Exact Sciences
EXAS
|
$115M |
| 2 |
Fate Therapeutics
FATE
|
$28.9M |
| 3 |
Beam Therapeutics
BEAM
|
$28.7M |
| 4 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$23.3M |
| 5 |
DMTK
DermTech, Inc. Common Stock
DMTK
|
$19M |
Top Sells
| 1 |
BLUE
bluebird bio
BLUE
|
$39.6M |
| 2 |
BNR
Burning Rock Biotech
BNR
|
$28.9M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$25.5M |
| 4 |
Relay Therapeutics
RLAY
|
$15M |
| 5 |
Adverum Biotechnologies
ADVM
|
$14.2M |
Sector Composition
| 1 | Healthcare | 86.11% |
| 2 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLUE
51
DELISTED
bluebird bio
BLUE
| – | – |
-915,000
| Closed | -$39.6M |
|
52
C4 Therapeutics
CCCC
$186M
| – | – |
-40,000
| Closed | -$1.33M |
|
|
53
Iovance Biotherapeutics
IOVA
$814M
| – | – |
-550,000
| Closed | -$25.5M |
|
|
AMRS
54
DELISTED
Amyris Inc.
AMRS
| – | – |
0
| – | – |
|
|
BMY.RT
55
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
| – | – |
-6,250,000
| Closed | -$4.31M |
|